Tower Research Capital (TRC)’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Tower Research Capital (TRC)’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18	Closed	–	–	6652
2023 Q1	$0	Buy	+18	New	+$235	﹤0.01%	6733
2022 Q4	–	Sell	-230	Closed	-$2K	–	6738
2022 Q3	$2K	Buy	230 +229	+22,900%	+$2.31K	﹤0.01%	5693
2022 Q2	$0	Buy	+1	New	+$10	﹤0.01%	6883

Tower Research Capital (TRC)'s ARCK Position: Q2 2023 in Review

Tower Research Capital (TRC) sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q2 2023, closing a stake of 18 shares.

Tower Research Capital (TRC) first reported a position in ARCK in Q2 2022 and held it in 3 quarters. The position peaked at $2K in Q3 2022. 0 funds tracked by Wall St. Rank hold ARCK as of Q2 2023.

Tower Research Capital (TRC) reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 18 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q2 2023.
Tower Research Capital (TRC) first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q2 2022 and held it in 3 quarters.
Tower Research Capital (TRC)'s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $2K in Q3 2022.
0 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q2 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.